Evidence map›Paper›PMID 39859436›Full record

ArticleInternational journal of molecular sciences2025

The Effect of Long-Term Cryopreservation on the Properties and Functionality of Platelet-Rich Plasma.

Maider Beitia, Jorge Guadilla, Jon Mercader Ruiz, Daniel Marijuan Pinel, Pello Sánchez, Ane Iriondo, Renato Andrade, João Espregueira-Mendes, Diego Delgado, Mikel Sánchez

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maider BeitiaAdvanced Biological Therapy Unit, Hospital Vithas Vitoria, 01008 Vitoria-Gasteiz, Spain.
Jorge GuadillaArthroscopic Surgery Unit, Hospital Vithas Vitoria, 01008 Vitoria-Gasteiz, Spain.
Jon Mercader RuizAdvanced Biological Therapy Unit, Hospital Vithas Vitoria, 01008 Vitoria-Gasteiz, Spain.
Daniel Marijuan PinelAdvanced Biological Therapy Unit, Hospital Vithas Vitoria, 01008 Vitoria-Gasteiz, Spain.
Pello SánchezAdvanced Biological Therapy Unit, Hospital Vithas Vitoria, 01008 Vitoria-Gasteiz, Spain.
Ane IriondoArthroscopic Surgery Unit, Hospital Vithas Vitoria, 01008 Vitoria-Gasteiz, Spain.
Renato AndradeClínica Espregueira-FIFA Medical Centre of Excellence, 4350-415 Porto, Portugal.ORCID 0000-0002-7636-7816
João Espregueira-MendesClínica Espregueira-FIFA Medical Centre of Excellence, 4350-415 Porto, Portugal.
Diego DelgadoAdvanced Biological Therapy Unit, Hospital Vithas Vitoria, 01008 Vitoria-Gasteiz, Spain.ORCID 0000-0002-0494-0804
Mikel SánchezAdvanced Biological Therapy Unit, Hospital Vithas Vitoria, 01008 Vitoria-Gasteiz, Spain.ORCID 0000-0001-9992-6927

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Platelet-Rich Plasma (PRP) is a biological treatment widely used in regenerative medicine for its restorative capacity. Although PRP is typically applied at the time of obtention, long-term storage and preservation could enhance its versatility and clinical applications. The objective of this study was to evaluate the effect of long-term freezing on PRP. For that, PRP and Platelet Lysates (PL) were collected and preserved at -20 °C and -80 °C for 6 and 12 months. The parameters analyzed included platelet count and size, fibrinogen levels, platelet activation percentage, growth factor (GF) levels, and bioactivity on cultured dermal fibroblasts. No significant changes in platelet count were found; however, variations in platelet size were observed. Platelets stored at -20 °C and -80 °C showed structural changes and increased activation over time, including membrane roughness and possible aggregation. GF analysis revealed a reduction in platelet-derived growth factors (PDGF-AB and VEGF), while extraplatelet factors like IGF-1 remained stable. Fibroblast cultures showed comparable cell viability when exposed to fresh and cryopreserved PRP and PL samples. These findings suggest that cryopreserving PRP at -20 °C or -80 °C for up to 12 months is a feasible approach for retaining its therapeutic potential, supporting its use in biobanking, and expanding clinical accessibility.

Indexed as

CryopreservationPlatelet-Rich PlasmaBlood PlateletsCells, CulturedCell SurvivalFibroblastsHumansPlatelet ActivationPlatelet CountPlatelet-Derived Growth FactorPlatelet-Derived Growth Factorplatelet-derived growth factor ABbioactivitycryopreservationgrowth factorsplatelet-rich plasmastorage

Identifiers

PMID39859436
PMCPMC11766244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.